The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

28 Aug 2015 15:31

RNS Number : 5121X
Fastnet Oil & Gas PLC
28 August 2015
 

28 August 2015

 

Fastnet Oil & Gas plc

("Fastnet" or the "Company")

Result of General Meeting, change of name and resignation of a Director

 

Fastnet (AIM: FAST, ESM: FOI), announces that at its General Meeting held earlier today at the Conrad London St James, 22-28 Broadway, London SW1H 0BH, the ordinary resolution approving the Investing Policy, along with the special resolution approving the change of name to Fastnet Equity plc, were duly passed. The voting in respect of each resolution was as follows:

 

Resolution

Number of votes for the resolution1

For

(%)1, 2

Number of votes against the resolution

Against

(%)2

Number of votes withheld3

To approve the Investing Policy

65,852,686

99.92

51,090

0.08

4,664,393

that the Company's name be changed to Fastnet Equity plc

65,854,751

99.93

49,025

0.07

4,664,393

 

Notes:

1. Proxy appointments totalling 192,873 shares gave discretion to the Chairman of the General Meeting and have been included in the "For" total of the appropriate resolution.

2. The number of shares in issue at 6.00 p.m. on 26 August 2015 was 345,369,071.

3. A vote "Withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "For" and "Against" a resolution.

 

Change of name

Dealings under the name "Fastnet Equity plc" are expected to commence at 8.00 am on Tuesday 1 September 2015. On change of the Company's name the Company's website will be www.fastnetequity.com.

 

Directorate change

As set out in the shareholder circular, following approval of the Proposals at today's General Meeting, Carol Law has today resigned as a director of the Company. Carol will continue as a consultant to the Company as she serves out her three month notice period.

 

Further announcements on the appointment of additional directors with life science experience will be made in due course.

 

Capitalised but undefined terms shall have the meaning given to them in the definitions appearing in the circular.

Cathal Friel, Non-Executive Chairman of Fastnet, commented:

"The Board is grateful for the support of the overwhelming majority of Shareholders, many of whom have suffered from the malaise in the oil industry as have the Board as significant Shareholders. The Board will work tirelessly to source Shareholder accretive deals for the Company in the healthcare sector and looks forward to updating shareholders on progress in the months ahead.

In terms of the Company's Celtic Sea Assets and 3D seismic survey data the Board will continue to examine all options to secure value for Shareholders. Options under consideration include spinning the Celtic Sea Assets into a stand-alone entity. This would enable any value creating opportunities from Celtic Sea Assets to benefit our existing Shareholders who would become shareholders in the newco."

 

For further information please contact:

Fastnet Oil & Gas plc

+353 (1) 644 0007

Cathal Friel, Non-Executive Chairman

Shore Capital

+44 (0) 20 7408 4090

Nomad

Bidhi Bhoma, Edward Mansfield

Corporate Broking

Jerry Keen

Davy

+353 (1) 679 6363

(ESM Adviser & Joint Broker)

John Frain, Anthony Farrell

Camarco

+44 (0) 20 3757 4980

Billy Clegg, Georgia Mann

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMPKFDNQBKDDFB
Date   Source Headline
24th Apr 20177:00 amRNSFirst Patient Enrolled
10th Apr 20175:21 pmRNSDirector/PDMR Shareholding
6th Apr 20174:13 pmRNSPosting of Annual Report 2016 and Notice of AGM
30th Mar 20177:00 amRNSFinal Results
28th Mar 20177:00 amRNSPhase 3 Clinical Trial for AP101 commenced
27th Mar 20177:00 amRNSSenior Management Appointment
8th Mar 20177:00 amRNSNotice of Results
6th Mar 20177:00 amRNSAP101 trial discussions completed with FDA & EMA
9th Feb 20177:00 amRNSDirectorate Change
7th Feb 20177:00 amRNSGrant of patent in Japan for AP101 (Episalvan)
6th Feb 20177:00 amRNSPre-clinical study results
5th Dec 20167:00 amRNSTransformational Licence Agreement
2nd Dec 20167:00 amRNSEUR20m Facility with European Investment Bank
7th Nov 20167:00 amRNSOrphan drug designation for Acromegaly Compound
19th Sep 20167:00 amRNSAppointment of Chief Medical Officer
13th Sep 20167:00 amRNSGrant of US patent for lead drug, Episalvan
13th Sep 20167:00 amRNSHalf-year Report
7th Jul 201612:54 pmRNSResult of AGM
27th Jun 20167:00 amRNSMarkus Ziener appointed as Non-Executive Director
9th Jun 20167:00 amRNSFinancial Results
2nd Jun 20164:34 pmRNSNotice of Results
21st Apr 20164:35 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSAdmission to trading on AIM and ESM
18th Apr 20162:30 pmRNSESM Schedule 1 Update
18th Apr 20162:30 pmRNSSchedule One update - Fastnet Equity plc
18th Apr 201612:41 pmRNSResult of General Meeting and Change of Name
31st Mar 20167:35 amRNSESM Schedule 1
31st Mar 20167:30 amRNSSchedule One - Fastnet Equity plc
31st Mar 20167:30 amRNSRestoration - Fastnet Equity plc
31st Mar 20167:00 amRNSProposed Acquisition of Amryt Pharmaceuticals
22nd Feb 20167:30 amRNSSuspension - Fastnet Equity plc
22nd Feb 20167:30 amRNSPotential Acquisition and Statement re Suspension
21st Dec 20157:01 amRNSAppointment of Non-executive Director
21st Dec 20157:00 amRNSInterim Results
18th Dec 20157:00 amRNSDemerger of Oil and Gas Assets
30th Sep 20153:12 pmRNSResult of Annual General Meeting
4th Sep 20157:00 amRNSFinal Results
28th Aug 20153:31 pmRNSResult of General Meeting
11th Aug 20153:35 pmRNSProposed adoption of Investing Policy/Notice of GM
3rd Jul 20153:22 pmRNSDirector/PDMR Shareholding
26th Jun 20152:45 pmRNSDirector/PDMR Shareholding
2nd Jun 20152:27 pmRNSHolding(s) in Company
1st Jun 20157:00 amRNSCorporate Update
26th Mar 20157:00 amRNSCeltic Sea Portfolio
27th Jan 201512:56 pmRNSDirectorate Change
9th Jan 201512:49 pmRNSHolding(s) in Company
2nd Jan 20157:00 amRNSExpiry of Tendrara Option Agreement
19th Dec 20147:00 amRNSInterim Results
10th Dec 20147:00 amRNSBoard changes & operational update
1st Dec 20143:00 pmRNSResponse to press speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.